Immunohistochemical Detection and Quantification of Minimal Residual
Disease with the Use of DBA.44 Antibody in Trephine Bone Marrow Biopsies
of Patients with Hairy Cell Leukemia
Dědič K.1, Žák P.2
1Fingerlandův ústav patologie, Lékařská fakulta v Hradci Králové, Univerzita Karlova, Praha2Oddělení klinické hematologie Fakultní nemocnice, Hradec Králové |
|
Summary:
Hairy cell leukemia patients treated with 2-chlorodeoxyadenosine or 2-deoxycoformicin achieve
a very high number of therapeutic responses. After complete remission, i.e. minimal residual
disease, we cannot demonstrate the disease activity, splenomegaly, or lymphadenopathy; moreover,
there comes to normalization of hemoglobin concentration, leukocyte count, and platelet
count. No leukemic cells in peripheral blood or bone marrow smears can be seen with the use of
staining techniques. They can be demonstrated immunohistochemically in decalcified trephine
bone marrow biopsies with the use of DBA.44 antibody together with their morphologic features.
For quantification of leukemic cells we use LUCIA-M image analysis.
Key words:
hairy cell leukemia – immunohistochemistry – minimal residual disease – trephine
bone marrow biopsy – DBA.44
|